Yusuke Hyodo

Relationship between n-3 Polyunsaturated Fatty Acids and Extent of Vessel Disease in Patients with ST Elevation Myocardial Infarction.

Journal: International heart journal

Published: November 21, 2017

Impact of Stent Type and Presence of Vasospastic Angina on Long-Term Prognosis.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: June 30, 2017

Stent Fracture and Peri-Stent Contrast Staining After Everolimus-Eluting Stent Implantation　- 5-Year Outcomes.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: June 20, 2017

Clinical and angiographic outcomes of axial stent deformations in unrestricted real world patient population.

Journal: Journal of interventional cardiology

Published: March 18, 2017

Difference in clinical presentations and related angiographic findings among early, late, and very late sirolimus-eluting stent failures requiring target lesion revascularization.

Journal: International journal of cardiology

Published: December 28, 2016

Long-term (8-10 years) outcomes after biodegradable polymer-coated biolimus-eluting stent implantation.

Journal: Heart (British Cardiac Society)

Published: September 09, 2016

Late Restenosis After Both First-Generation and Second-Generation Drug-Eluting Stent Implantations Occurs in Patients With Drug-Eluting Stent Restenosis.

Journal: Circulation. Cardiovascular interventions

Published: August 25, 2016

Five-Year Outcomes After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent Restenosis.

Journal: The American journal of cardiology

Published: August 24, 2016

Ten-year clinical outcomes after sirolimus-eluting stent implantation: Impact of an in-stent restenosis target lesion.

Journal: American heart journal

Published: November 21, 2015

Incidence, predictive factors, and clinical impact of stent recoil in stent fracture lesion after drug-eluting stent implantation.

Journal: International journal of cardiology

Published: August 14, 2015

Stent Fracture After Sirolimus-Eluting Stent Implantation: 8-Year Clinical Outcomes.

Journal: Circulation. Cardiovascular interventions

Published: August 01, 2015

Late Restenosis After Paclitaxel-Coated Balloon Angioplasty Occurs in Patients With Drug-Eluting Stent Restenosis.

Journal: Journal of the American College of Cardiology

Published: March 04, 2015

Relationship between n-3 Polyunsaturated Fatty Acids and Extent of Vessel Disease in Patients with ST Elevation Myocardial Infarction.

Relationship between n-3 Polyunsaturated Fatty Acids and Extent of Vessel Disease in Patients with ST Elevation Myocardial Infarction.

Impact of Stent Type and Presence of Vasospastic Angina on Long-Term Prognosis.

Impact of Stent Type and Presence of Vasospastic Angina on Long-Term Prognosis.

Stent Fracture and Peri-Stent Contrast Staining After Everolimus-Eluting Stent Implantation - 5-Year Outcomes.

Stent Fracture and Peri-Stent Contrast Staining After Everolimus-Eluting Stent Implantation - 5-Year Outcomes.

Clinical and angiographic outcomes of axial stent deformations in unrestricted real world patient population.

Clinical and angiographic outcomes of axial stent deformations in unrestricted real world patient population.

Difference in clinical presentations and related angiographic findings among early, late, and very late sirolimus-eluting stent failures requiring target lesion revascularization.

Difference in clinical presentations and related angiographic findings among early, late, and very late sirolimus-eluting stent failures requiring target lesion revascularization.

Long-term (8-10 years) outcomes after biodegradable polymer-coated biolimus-eluting stent implantation.

Long-term (8-10 years) outcomes after biodegradable polymer-coated biolimus-eluting stent implantation.

Late Restenosis After Both First-Generation and Second-Generation Drug-Eluting Stent Implantations Occurs in Patients With Drug-Eluting Stent Restenosis.

Late Restenosis After Both First-Generation and Second-Generation Drug-Eluting Stent Implantations Occurs in Patients With Drug-Eluting Stent Restenosis.

Five-Year Outcomes After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent Restenosis.

Five-Year Outcomes After Paclitaxel-Coated Balloon Angioplasty for Drug-Eluting Stent Restenosis.

Ten-year clinical outcomes after sirolimus-eluting stent implantation: Impact of an in-stent restenosis target lesion.

Ten-year clinical outcomes after sirolimus-eluting stent implantation: Impact of an in-stent restenosis target lesion.

Incidence, predictive factors, and clinical impact of stent recoil in stent fracture lesion after drug-eluting stent implantation.

Incidence, predictive factors, and clinical impact of stent recoil in stent fracture lesion after drug-eluting stent implantation.

Stent Fracture After Sirolimus-Eluting Stent Implantation: 8-Year Clinical Outcomes.

Stent Fracture After Sirolimus-Eluting Stent Implantation: 8-Year Clinical Outcomes.

Late Restenosis After Paclitaxel-Coated Balloon Angioplasty Occurs in Patients With Drug-Eluting Stent Restenosis.

Late Restenosis After Paclitaxel-Coated Balloon Angioplasty Occurs in Patients With Drug-Eluting Stent Restenosis.

Stent Fracture and Peri-Stent Contrast Staining After Everolimus-Eluting Stent Implantation　- 5-Year Outcomes.

Stent Fracture and Peri-Stent Contrast Staining After Everolimus-Eluting Stent Implantation　- 5-Year Outcomes.